{"input_url":"https://www.nature.com/articles/s41467-026-72038-y","gnews_decode":"https://www.nature.com/articles/s41467-026-72038-y","http_status":200,"final_url":"https://www.nature.com/articles/s41467-026-72038-y","html_length":549279,"trafilatura_result":"ok","text_length":79334,"text_preview":"Abstract\nThe use of immunosuppressive therapies for rheumatoid arthritis (RA) is associated with substantial adverse effects. In addition, existing diagnostic reagents are limited in their ability to detect local joint damage. Here, we address both these needs using a collagen-hybridizing peptide (C","verdict":"OK"}